Relation between uric acid and Alzheimer's disease in elderly Jordanians

Journal of Alzheimer's Disease

Volumn 44, Issue 3, 2015, Pages 859-865

  Al Khateeb, Eman ^a   Althaher, Arwa ^a   Al Khateeb, Mohammed ^a   Al Musawi, Hanan ^a   Azzouqah, Ola ^a   Al Shweiki, Samir ^a   Shafagoj, Yanal ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Aging; Alzheimer's disease; biomarkers; cholesterol; dementia; lipid profile; uric acid

Indexed keywords

LIPID; URIC ACID;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; JORDANIAN; LIPID BLOOD LEVEL; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL; BLOOD; COGNITION DISORDERS; COMPLICATION; GERIATRICS; JORDAN; MENTAL HEALTH; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; GERIATRICS; HUMANS; JORDAN; LIPIDS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; URIC ACID;

EID: 84922590859     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-142037     Document Type: Article

References (41)

1. Al-Makhamreh S, Hasna F, Al-Khateeb E (2011) The forgotten few: The social context of ageing and Alzheimer's disease in Jordan. British Society of Gerontology's Generations Review, http://www. britishgerontology. org/DB/gr-editions-2/generations-review/the-forgotten-few-the-social-contextof-ageing-a-2. html.
2. Christen Y (2000) Oxidative stress and Alzheimer disease. Am J Clin Nutr 71, 621-629.
3. Zhu X, Raina AK, Perry G, Smith MA (2004) Alzheimer's disease: The two-hit hypothesis. Lancet Neurol 3, 219-226.
4. Smith MA, Nunomura A, Zhu X, Takeda A, Perry G (2000) Metabolic, metallic, and mitotic sources of oxidative stress in AD. Redox Signal 2, 413-420.
5. Sparks DL, Petanceska S, Sabbagh M, Connor D, Soares H, Adler C, Lopez J, Ziolkowski C, Lochhead J, Browne P (2005) Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT). Curr Alzheimer Res 2, 495-496.
6. Tan Z, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease: The Framingham Study. Arch Intern Med 163, 1053-1057.
7. Caramelli P, Nitrini R, Maranhao R, Lourenço ACG, Damasceno MC, Vinagre C, Caramelli B (1999) Increase apolipoprotin B serum concentration in Alzheimer's disease. Acta Neurol Scand 100, 61-63.
8. Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality; The NHANES I epidemiologic follow-up study, 1971-1992. JAMA 283, 2404-2410.
9. Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Breteler MMB (2006) Uric acid is a risk factor for myocardial infarction and stroke; The Rotterdam Study. Stroke 37, 1503-1510.
10. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J,Watanabe S, Rodriguez-Iturbe R, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41, 1183-1190.
11. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84, 407-412.
12. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 24, 915-919.
13. Kim TS, Pae CU, Yoon SJ, JangWY, Lee NJ, Kim JJ, Lee SJ, Lee C, Paik IH, LeeCU(2006) Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry 21, 344-348.
14. Irizarry MC, Raman R, Schwarzschild MA, Becerra LM, Thomas RG, Peterson RC, Ascherio A, Aisen PS (2009) Plasma urate and progression of mild cognitive impairment. Neurodegener Dis 6, 23-28.
15. Polidori MC, Mecocci P (2002) Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J Alzheimers Dis 4, 517-522.
16. Al-khateeb E, Al-zayadneh E, Al-dalahmah O, Alawadi Z, Khatib F, Naffa R, Shafagoj Y (2014) Relation between copper, lipid profile, and cognition in elderly Jordanians. J Alzheimers Dis 41, 203-211.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of AD; report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on AD. Neurology 34, 939-944.
18. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414.
19. Folstein MF, Folstein SE, McHugh PR (1975) Mini Mental State. A practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12, 189-198.
20. Ruiz García A, Sánchez Armengol A, LuqueCrespo E, García Aguilar D, Romero Falcón A, Carmona Bernal C, Capote F (2006) Blood uric acid levels in patients with sleep-disordered breathing. Arch Bronconeumol 42, 492-500.
21. Siedel J, Hagele EO, Ziegenhorn J, Wahiefeld AW (1983) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin. Chem 29, 1075-1080.
22. Lopes-VirellaMF, Stone P, Ellis S, Colwell JA(1977) Cholesterol determination in high-density lipoproteins separation by three different methods. Clin Chem 23, 882-884.
23. National Cholesterol Education Program: Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). NIH Publication 01-3670, (2001).
24. SternY, Alexander GE, Prohovnik I, MayeuxR(1992) Inverse relationship between education &parietotemporal perfusion deficit in AD. Ann Neurol 32, 371-375.
25. Gatz M (2005) Educating the brain to avoid dementia: Can mental exercise prevent Alzheimer disease? PLoS Med 2, e7.
26. Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci U S A 78, 6858-6862.
27. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P (1986) Uric acid iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 235, 747-754
28. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87, 315-424.
29. Van der Veen RC, Hinton DR, Incardonna F, Hofman FM (1997) Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol 77, 1-7.
30. Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley AC (1992) plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 21, 91-94.
31. Spitsin S, Hooper DC, Mikheeva T, Koprowski H (2001) Uric acid levels in patients with multiple sclerosis: Analysis in mono-and dizygotic twins. Mult Scler 7, 165-166.
32. Toncev G, Milicic B, Toncev S, Samardzic G (2002) Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol 9, 221-226.
33. Rentzos M, Nikolaou C, Anagnostouli M, Rombos A, Tsakanikas K, Economou M, Dimitrakopoulos A, Karouli M, Vassilopoulos D (2006) Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg 108, 527-531.
34. Drulovic J, Dujmovic I, Stojsavljevic N, Mesaros S, Andjelkovic S, Miljkovic D, Peric V, Dragutinovic G, Marinkovic J, Levic Z, StojkovicMM(2001) Uric acid levels in sera from patients with multiple sclerosis. J Neurol 248, 121-126.
35. Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV (2000) Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 14, 691-698.
36. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349, 151-154.
37. Sabbagh M, Zahiri HR, Ceimo J, Cooper K, GaulW, Connor D, Sparks DL (2004) Is there a characteristic lipid profile in Alzheimer's disease? J Alzheimers Dis 6, 585-589.
38. Smith MA, Richey PL, Taneda S.,Kutty RK, Sayre LM,Monnier VM, Perry G (1994) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease, Ann N Y Acad Sci 738, 447-454.
39. Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical ageing in Alzheimer's disease. Trends Neurosci 18, 172-176.
40. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
41. Smith MA, Richey PL, Harris LM, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17 2653-2657.